Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idex (IEX) EBT (2016 - 2025)

Idex (IEX) has disclosed EBT for 17 consecutive years, with $167.7 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 10.91% to $167.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $632.6 million, a 1.05% decrease, with the full-year FY2025 number at $632.6 million, down 1.05% from a year prior.
  • EBT was $167.7 million for Q4 2025 at Idex, down from $170.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $261.8 million in Q3 2023 to a low of $124.5 million in Q1 2025.
  • A 5-year average of $168.1 million and a median of $165.6 million in 2022 define the central range for EBT.
  • Peak YoY movement for EBT: skyrocketed 51.2% in 2022, then tumbled 41.02% in 2024.
  • Idex's EBT stood at $153.2 million in 2021, then rose by 6.71% to $163.5 million in 2022, then fell by 14.25% to $140.2 million in 2023, then rose by 7.85% to $151.2 million in 2024, then rose by 10.91% to $167.7 million in 2025.
  • Per Business Quant, the three most recent readings for IEX's EBT are $167.7 million (Q4 2025), $170.5 million (Q3 2025), and $169.9 million (Q2 2025).